BOCHK Asset Management Ltd bought a new position in International Business Machines Corporation (NYSE:IBM - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 6,600 shares of the technology company's stock, valued at approximately $1,955,000. International Business Machines makes up 0.5% of BOCHK Asset Management Ltd's investment portfolio, making the stock its 16th largest position.
A number of other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in International Business Machines by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 95,776,307 shares of the technology company's stock worth $27,024,243,000 after purchasing an additional 724,832 shares in the last quarter. Capital World Investors boosted its stake in International Business Machines by 13.9% in the 3rd quarter. Capital World Investors now owns 17,045,156 shares of the technology company's stock worth $4,809,461,000 after purchasing an additional 2,077,506 shares in the last quarter. Legal & General Group Plc boosted its stake in International Business Machines by 2.5% in the 3rd quarter. Legal & General Group Plc now owns 7,302,722 shares of the technology company's stock worth $2,060,536,000 after purchasing an additional 176,219 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in International Business Machines by 0.9% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,563,164 shares of the technology company's stock worth $1,639,966,000 after purchasing an additional 46,924 shares in the last quarter. Finally, Amundi boosted its stake in International Business Machines by 17.9% in the 3rd quarter. Amundi now owns 4,777,516 shares of the technology company's stock worth $1,382,695,000 after purchasing an additional 725,191 shares in the last quarter. 58.96% of the stock is currently owned by institutional investors and hedge funds.
International Business Machines Stock Performance
Shares of NYSE IBM opened at $237.31 on Friday. The company has a current ratio of 0.96, a quick ratio of 0.92 and a debt-to-equity ratio of 1.67. International Business Machines Corporation has a 12 month low of $220.72 and a 12 month high of $324.90. The company has a 50 day simple moving average of $255.75 and a two-hundred day simple moving average of $283.31. The stock has a market cap of $222.61 billion, a price-to-earnings ratio of 21.28, a PEG ratio of 2.41 and a beta of 0.69.
International Business Machines (NYSE:IBM - Get Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $4.52 EPS for the quarter, beating the consensus estimate of $4.33 by $0.19. International Business Machines had a net margin of 15.69% and a return on equity of 38.15%. The business had revenue of $19.69 billion during the quarter, compared to analysts' expectations of $19.23 billion. During the same period in the previous year, the business posted $3.92 EPS. The business's quarterly revenue was up 12.2% compared to the same quarter last year. As a group, analysts predict that International Business Machines Corporation will post 10.78 earnings per share for the current year.
International Business Machines Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 10th were issued a dividend of $1.68 per share. This represents a $6.72 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Tuesday, February 10th. International Business Machines's payout ratio is 60.27%.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on IBM shares. DZ Bank upgraded shares of International Business Machines to a "hold" rating in a research note on Wednesday, February 11th. BMO Capital Markets decreased their price objective on shares of International Business Machines from $350.00 to $290.00 and set a "market perform" rating for the company in a research note on Thursday, March 19th. Oppenheimer set a $380.00 price objective on shares of International Business Machines and gave the company an "outperform" rating in a research note on Thursday, January 29th. Wall Street Zen cut shares of International Business Machines from a "buy" rating to a "hold" rating in a research note on Sunday, January 11th. Finally, Jefferies Financial Group restated a "buy" rating on shares of International Business Machines in a research note on Monday, February 23rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $311.27.
Read Our Latest Report on International Business Machines
Trending Headlines about International Business Machines
Here are the key news stories impacting International Business Machines this week:
Insider Activity at International Business Machines
In other news, Director David N. Farr bought 1,000 shares of the business's stock in a transaction dated Friday, January 30th. The stock was purchased at an average cost of $304.00 per share, with a total value of $304,000.00. Following the acquisition, the director directly owned 9,258 shares in the company, valued at $2,814,432. This trade represents a 12.11% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Michael Miebach bought 434 shares of the business's stock in a transaction dated Wednesday, February 25th. The shares were purchased at an average cost of $233.33 per share, with a total value of $101,265.22. Following the completion of the acquisition, the director owned 434 shares in the company, valued at approximately $101,265.22. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 1,484 shares of company stock valued at $417,157. Insiders own 0.27% of the company's stock.
About International Business Machines
(
Free Report)
International Business Machines Corporation (IBM) is a global technology and consulting company headquartered in Armonk, New York. Founded in 1911 as the Computing-Tabulating-Recording Company (CTR) and renamed IBM in 1924, the company has evolved from early electromechanical machines to a diversified technology provider serving enterprises and governments worldwide. IBM is publicly traded on the New York Stock Exchange under the ticker symbol IBM.
IBM's principal businesses encompass cloud computing and software, infrastructure and systems, consulting and technology services, and research and development.
Read More
Want to see what other hedge funds are holding IBM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for International Business Machines Corporation (NYSE:IBM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider International Business Machines, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Business Machines wasn't on the list.
While International Business Machines currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report